Corvus Pharmaceuticals reports executive or director departure via 8-K filing

Corvus Pharmaceuticals filed an 8-K form disclosing a change in corporate governance or executive leadership under Item 5.02. The specific identity of the departing individual and the nature of the transition remain to be detailed in the full filing text.